These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21394915)

  • 1. Divide and conquer: the genetic basis of molecular subclassification of breast cancer.
    Kristensen VN
    EMBO Mol Med; 2011 Apr; 3(4):183-5. PubMed ID: 21394915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of epigenetic biomarkers in breast cancer.
    Parrella P
    Biomark Med; 2018 Sep; 12(9):937-940. PubMed ID: 30041537
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterogeneity of drug target expression among metastatic lesions: lessons from a breast cancer autopsy program.
    Steeg PS
    Clin Cancer Res; 2008 Jun; 14(12):3643-5. PubMed ID: 18559575
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory mechanisms and clinical significance of vimentin in breast cancer.
    Chen Z; Fang Z; Ma J
    Biomed Pharmacother; 2021 Jan; 133():111068. PubMed ID: 33378968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of adenoid cystic carcinoma of the breast with emphasis on its molecular and genetic characteristics.
    Vranic S; Bender R; Palazzo J; Gatalica Z
    Hum Pathol; 2013 Mar; 44(3):301-9. PubMed ID: 22520948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ErbB4 in breast cancer.
    Sundvall M; Iljin K; Kilpinen S; Sara H; Kallioniemi OP; Elenius K
    J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):259-68. PubMed ID: 18454307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of breast cancer cells to mesenchymal stem cells: a possible role of inflammation by breast implants.
    Orciani M; Bolletta E; Campanati A; Di Benedetto G; Di Primio R
    Plast Reconstr Surg; 2014 Dec; 134(6):994e-996e. PubMed ID: 25415129
    [No Abstract]   [Full Text] [Related]  

  • 8. Biologic characteristics of premalignant breast disease.
    Cole K; Tabernero M; Anderson KS
    Cancer Biomark; 2010; 9(1-6):177-92. PubMed ID: 22112476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?
    Lopez-Bonet E; Menendez JA
    Ann Oncol; 2010 Apr; 21(4):901-902. PubMed ID: 20032125
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
    Liu B; Tian Y; Li F; Zhao Z; Jiang X; Zhai C; Han X; Zhang L
    Oncol Rep; 2016 Jun; 35(6):3178-84. PubMed ID: 27109339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of molecular detection of CK19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically negative axillary lymph nodes.
    Pitini V; Arrigo C; Amata C; La Torre I
    Ann Oncol; 2005 Nov; 16(11):1845; author reply 1845-6. PubMed ID: 15972276
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging role of circular RNAs in breast cancer.
    Ghafouri-Fard S; Hussen BM; Taheri M; Ayatollahi SA
    Pathol Res Pract; 2021 Jul; 223():153496. PubMed ID: 34052769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where and by whom should gastric cancer HER2/neu status be assessed?: lessons from breast cancer.
    Salto-Tellez M; Yau EX; Yan B; Fox SB
    Arch Pathol Lab Med; 2011 Jun; 135(6):693-5. PubMed ID: 21631260
    [No Abstract]   [Full Text] [Related]  

  • 14. Ret Receptor Has Distinct Alterations and Functions in Breast Cancer.
    Gattelli A; Hynes NE; Schor IE; Vallone SA
    J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):13-26. PubMed ID: 32080788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASO Author Reflections: The Changing Role of Gene Expression Profiling in ER+/HER2- Breast Cancer.
    van Steenhoven JEC; van Dalen T
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):800-801. PubMed ID: 31650304
    [No Abstract]   [Full Text] [Related]  

  • 16. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
    Liu R; Guo CX; Zhou HH
    Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
    Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
    J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BP1, a potential biomarker for breast cancer prognosis.
    Lou Y; Fallah Y; Yamane K; Berg PE
    Biomark Med; 2018 May; 12(5):535-545. PubMed ID: 29575937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Status of Long Non-Coding RNAs in Human Breast Cancer.
    Cerk S; Schwarzenbacher D; Adiprasito JB; Stotz M; Hutterer GC; Gerger A; Ling H; Calin GA; Pichler M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EndoPredict versus uPA/PAI-1 in breast cancer: Comparison of markers and association with clinicopathological parameters.
    Jakubowicz E; Martin B; Hoffmann R; Kröncke T; Jung T; Steierl R; Steinfeld D; Schenkirsch G; Kriegsmann J; Märkl B
    Breast J; 2019 May; 25(3):450-454. PubMed ID: 31001905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.